XNAS
ATER
Market cap13mUSD
Jul 09, Last price
1.19USD
1D
-4.03%
1Q
76.56%
IPO
-98.92%
Name
Aterian Inc
Chart & Performance
P/E
—
P/S
0.19
EPS
—
Div Yield, %
—
Shrs. gr., 5y
-16.02%
Rev. gr., 5y
-17.97%
Revenues
69m
-30.36%
Net income
-19m
L+60.04%
CFO
-11m
L
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Aterian, Inc., founded in 2014 and headquartered in New York, is an international, technology-driven consumer products company. Its core innovation is an Artificial Intelligence Marketplace e-Commerce Engine, a proprietary software platform that leverages machine learning, natural language processing, and data analytics to streamline the design, development, marketing, and sales of various products. The company offers a wide array of goods, including home and kitchen appliances, kitchenware, heating and cooling devices, health and beauty products, and air quality solutions like dehumidifiers, humidifiers, and air conditioners. These items, along with essential oils, are sold under numerous brands such as hOmeLabs, Vremi, Squatty Potty, Xtava, RIF6, Aussie Health, Holonix, Truweo, Mueller, Pursteam, Pohl and Schmitt, Healing Solutions, Photo Paper Direct, and Spiralizer. Aterian primarily caters to individual online consumers, distributing its products through major e-commerce platforms like Amazon, its own websites, and other digital marketplaces. The company officially changed its name from Mohawk Group Holdings, Inc. to Aterian, Inc. in April 2021.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||